The plant kingdom has been the most significant source of anticancer drugs. These include alkaloids, diterpenes, tannins, phenolics, lignans, glycosides which have exhibited lesser toxicity than conventional drugs. In leukaemia, the human body is susceptible to infections due to the replacement of normal leucocytes replaced by a large number of immature cells. Chemotherapy for leukaemia is associated with side effects and drug resistance by the leukemic cells. Cytotoxic agents with higher efficacy and lesser side effects are good candidates in cancer therapy, and plant metabolites serve as potential bioactive agents in anticancer drug formulations. This review article discusses the anti-leukemic properties of compounds obtained from plants and the mechanism of anti-leukemic activity induced by each of these plants. Effect of plants and their metabolites on different leukemic cell lines such as HL60, Kasumi-1, CCRF-CEM, K-562, U-937, THP-1 and MOLT-3 was compared. The findings showed anti-leukemic activity through cell cycle arrest, DNA damage, destruction of mitochondrial function, suppression of tumour genes, apoptosis-inducing enzymes and cytotoxic activities of plants and their derivatives. Based on extensive research findings from this review, phytochemicals and their derived analogues possess the most promising option for the better and less toxic anti-leukemic treatment. Identification of the mechanism of action by the plant bioactive compounds helps in developing standard herbal medicines for effective leukaemia treatment.
Read full abstract